Project Grant R01DK143671
Award Date
9/15/24
Completion Date
7/31/29
Dollars Obligated
$1.6M
Funding Federal Agency
Office of the Director
Awarding Federal Agency
National Institute of Diabetes and Digestive and Kidney Diseases
Federal Grant Program
93.310
Assistance Type
Project Grant
Place of Performance
Los Angeles, CA 90089, USA
Similar Awards
This $225,306 Project Grant award from the National Science Foundation (NSF) Biological Sciences program (CFDA 47.074) supports a collaborative research project between researchers at the University of Southern California (USC) and a German partner to investigate the long-term impact of early-life growth signals on adult hematopoietic (blood) stem cell function and selection. The key products and services to be delivered under this 3-year award include: 1) using stem cell transplantation and...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $734,607 to Boston Medical Center Corporation to conduct research on the mechanisms regulating the migration of hematopoietic stem cells (HSCs) into the bone marrow niche. The goal is to elucidate the key endothelial cell processes, including adhesion and endocytosis/vesicle trafficking, that facilitate the trans-endothelial...
This Project Grant award of $153,696 from the National Institute on Aging (CFDA 93.866 Aging Research) to The Leland Stanford Junior University aims to investigate the developmental origins and functional characteristics of myeloid-biased hematopoietic stem cells (MY-HSCs). The research will utilize advanced techniques like flow cytometry, single-cell RNA sequencing, and lineage tracing to analyze the localization, frequency, and transcriptional profiles of HOXB5+NEO1+ MY-HSCs during prenatal...
This $159,512 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) supports the generation of a comprehensive single-cell transcriptomic and epigenomic map of human bone marrow cells. The project aims to establish the mesenchymal cell hierarchy in human bone, providing insight into how cell fates are regulated and the cell-cell interactions that support cell fate decisions. This will involve isolating single-cell suspensions from...
This federal Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $146,876 to the Coriell Institute for Medical Research to develop new methods for expanding functional hematopoietic stem cells (HSCs) from cryopreserved umbilical cord blood (UCB) samples. The project aims to optimize an approach using PPAR-α agonists, which have been shown to significantly expand long-term functional UCB HSCs...
This $1,458,982 Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), aims to identify small molecule compounds that can activate the endoplasmic reticulum associated degradation (ERAD) pathway to support ex vivo expansion of hematopoietic stem cells (HSCs). The research will test the hypothesis that loss of ERAD activity is associated with the decline of functional HSCs during ex vivo culture, and that...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), provides $497,806.97 to the Trustees of Indiana University, doing business as Indiana University Indianapolis, for a 3-year research project. The research aims to elucidate molecular programs that can be targeted to enhance the function of hematopoietic stem cells (HSCs) derived from umbilical cord blood, with the goal of improving hematopoietic...
This Project Grant award from the National Heart, Lung, and Blood Institute (NHLBI), under the Cardiovascular Diseases Research program (CFDA 93.837), supports research to understand the role of hypoxia (low oxygen) in regulating hematopoietic stem cell (HSC) function and self-renewal. The $792,498 award to Trustees of Indiana University, Indianapolis will fund a 4-year study to examine how hypoxia alters gene expression, signaling pathways, and metabolic processes in HSCs to enhance their...
The National Heart, Lung, and Blood Institute (NHLBI) of the National Institutes of Health (NIH) awarded a $1,123,357 Project Grant under the Cardiovascular Diseases Research program (CFDA 93.837) to Childrens Hospital Medical Center in Cincinnati, Ohio. The funding supports a 7-year research program to investigate the specialized microenvironments within bone marrow that regulate blood cell production and response to inflammation. The research aims to define the spatial organization of the bone...
This $677,600 Project Grant award from the National Heart, Lung, and Blood Institute (CFDA 93.837 Cardiovascular Diseases Research) aims to gain a mechanistic understanding of erythroid progenitor (EP) self-renewal, both in vitro and in vivo. The primary goals are to: Test the hypothesis that the BMI1/RING1B chromatin modulators regulate human self-renewing erythroblast (SRE) self-renewal through epigenetic control of transcription and cholesterol homeostasis. Test the hypothesis that...